Author: Robert Michel

Biogen Idec’s Tecfidera (dimethyl fumarate) has been approved by the FDA for the treatment of people with relapsing forms of multiple sclerosis (MS).  The wholesale acquisition price for Tecfidera is reported to be $54,900,  about 9% less than the first MS …

Tecfidera for MS is $55,000 per year. Why? Read More »

Tagged with: , , , , , ,

Go read “Macrophages are required for adult salamander limb regeneration”. Unfortunately, gaining an understanding of the identity of the “…macrophage-derived therapeutic molecules…” that “..may therefore aid in the regeneration of damaged body parts…” could take quite a few years given the pace of …

Salamanders, regrowing new body parts, and pharma! Read More »

Tagged with: , , , , , ,